Moderna
MRNA
#1197
Rank
โ‚น1.292 T
Marketcap
โ‚น3,358
Share price
-5.62%
Change (1 day)
-42.52%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น1.292 Trillion

As of November 2024 Moderna has a market cap of โ‚น1.292 Trillion. This makes Moderna the world's 1197th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น1.292 T-59.07%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of Moderna was reported to be:

โ‚น1.369 Trillion
by Nasdaq info icon info icon
โ‚น1.369 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น8.29 B-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.007 T 1,525.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น70.34 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.808 T 117.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น17.509 T 1,255.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น224.71 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น30.871 T 2,289.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น251.40 B-80.54%๐Ÿ‡บ๐Ÿ‡ธ USA